These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 9276158)

  • 1. Aprotinin, an antifibrinolytic drug, attenuates bradykinin-induced permeability in conscious rats via platelets and neutrophils.
    O'Brien JG; Battistini B; Farmer P; Johnson RJ; Zaharia F; Plante GE; Sirois P
    Can J Physiol Pharmacol; 1997 Jun; 75(6):741-9. PubMed ID: 9276158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tranexamic acid and aprotinin, two antifibrinolytic drugs, on PAF-induced plasma extravasation in unanesthetized rats.
    O'Brien JG; Battistini B; Zaharia F; Plante GE; Sirois P
    Inflammation; 2000 Oct; 24(5):411-29. PubMed ID: 10921506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
    Vianna RM; Calixto JB
    Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tranexamic acid and aprotinin on PAF-induced vascular permeability in normal, thrombocytopenic or neutropenic rats.
    O'Brien JG; Farmer P; Battistini B; Johnson RJ; Zaharia F; Sirois P
    Inflamm Res; 1997 Aug; 46 Suppl 2():S145-6. PubMed ID: 9297553
    [No Abstract]   [Full Text] [Related]  

  • 5. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion.
    Wachtfogel YT; Kucich U; Hack CE; Gluszko P; Niewiarowski S; Colman RW; Edmunds LH
    J Thorac Cardiovasc Surg; 1993 Jul; 106(1):1-9; discussion 9-10. PubMed ID: 7686593
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood-tumor barrier by opening tight junction.
    Zhang Z; Xia C; Xue Y; Liu Y
    J Neurosci Res; 2009 Aug; 87(10):2282-9. PubMed ID: 19326437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a selective bradykinin B1 receptor antagonist on increased plasma extravasation in streptozotocin-induced diabetic rats: distinct vasculopathic profile of major key organs.
    Lawson SR; Gabra BH; Nantel F; Battistini B; Sirois P
    Eur J Pharmacol; 2005 May; 514(1):69-78. PubMed ID: 15878326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes mediate rapid alterations in microvascular permeability: roles for neutrophils, complement, and platelets.
    Lister KJ; James WG; Hickey MJ
    Microcirculation; 2007; 14(7):709-22. PubMed ID: 17885996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interference of neutrophil-platelet interaction by YC-1: a cGMP-dependent manner on heterotypic cell-cell interaction.
    Liao CH; Cheng JT; Teng CM
    Eur J Pharmacol; 2005 Sep; 519(1-2):158-67. PubMed ID: 16112105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of PAF on rat lung vascular permeability: role of platelets and polymorphonuclear leucocytes.
    Sirois MG; de Lima WT; de Brum Fernandes AJ; Johnson RJ; Plante GE; Sirois P
    Br J Pharmacol; 1994 Apr; 111(4):1111-6. PubMed ID: 8032597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human urotensin-II enhances plasma extravasation in specific vascular districts in Wistar rats.
    Gendron G; Simard B; Gobeil F; Sirois P; D'Orléans-Juste P; Regoli D
    Can J Physiol Pharmacol; 2004 Jan; 82(1):16-21. PubMed ID: 15052301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation.
    Asimakopoulos G; Thompson R; Nourshargh S; Lidington EA; Mason JC; Ratnatunga CP; Haskard DO; Taylor KM; Landis RC
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):361-9. PubMed ID: 10917955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PAF-acether-induced plasma exudation in rat skin is independent of platelets and neutrophils.
    Pirotzky E; Page CP; Roubin R; Pfister A; Paul W; Bonnet J; Benveniste J
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):107-22. PubMed ID: 6546141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neutrophil adhesion on the size of aggregates formed by agonist-activated platelets.
    Koda M; Banno Y; Naganawa T
    Platelets; 2005 Dec; 16(8):482-91. PubMed ID: 16287615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MEN16132, a novel potent and selective nonpeptide kinin B2 receptor antagonist: in vivo activity on bradykinin-induced bronchoconstriction and nasal mucosa microvascular leakage in anesthetized guinea pigs.
    Valenti C; Cialdai C; Giuliani S; Lecci A; Tramontana M; Meini S; Quartara L; Maggi CA
    J Pharmacol Exp Ther; 2005 Nov; 315(2):616-23. PubMed ID: 16027229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endotoxin-induced plasma exudation in guinea-pig airways in vivo and the effect of neutrophil depletion.
    Evans TW; Rogers DF; Belvisi MG; Rohde JA; Chung KF; Barnes PJ
    Eur Respir J; 1990 Mar; 3(3):299-303. PubMed ID: 2187707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of alpha-naphthyl thiourea-induced lung injury by prostaglandin E1 and platelet depletion.
    Fantone JC; Kunkel RG; Kinnes DA
    Lab Invest; 1984 Jun; 50(6):703-10. PubMed ID: 6233454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [T-kinin-induced increase in airway vascular permeability and its modulation by angiotensin-converting enzyme].
    Takeda Y; Tamaoki J; Yamawaki I; Chiyotani A; Konno K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):627-31. PubMed ID: 8741526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clot lysis time in platelet-rich plasma: method assessment, comparison with assays in platelet-free and platelet-poor plasmas, and response to tranexamic acid.
    Panes O; Padilla O; Matus V; Sáez CG; Berkovits A; Pereira J; Mezzano D
    Platelets; 2012; 23(1):36-44. PubMed ID: 21787173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age-dependent differential development of leukotactic and vasoactive responsiveness to acute inflammatory mediators.
    Angle MJ; McManus LM; Pinckard RN
    Lab Invest; 1986 Dec; 55(6):616-21. PubMed ID: 3465972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.